ADMA Biologics, Inc. (ADMA)
8.12
+0.06
(+0.74%)
USD |
NASDAQ |
Jun 09, 16:00
8.12
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Research and Development Expense (Quarterly) : 2.597M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Inovio Pharmaceuticals, Inc. | 13.75M |
| Zenas BioPharma, Inc. | 60.44M |
| Marker Therapeutics, Inc. | 2.843M |
| Praxis Precision Medicines, Inc. | 77.99M |